Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study

Morgan, Steven G.; Hunt, Jordan; Rioux, Jocelyn; Proulx, J.; Weymann, Deirdre; Tannenbaum, Cara

doi:10.9778/cmajo.20150131

Cited by 98 publications

(83 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2013, more than one in three Canadians (37%) over age 65 filled at least one prescription for medicines believed to pose unnecessary risks for older adults – at a total direct cost of over $400 million for prescriptions alone (Morgan et al In Press). Such prescribing has negative impacts on patient health and health system demands.…”

Section: Specific Objectives and Strategic Actionsmentioning

confidence: 99%

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada

Morgan

Gagnon

Mintzes

et al. 2016

hcpol

View full text Add to dashboard Cite

Canada needs a national strategy to fulfill its obligation to ensure universal access to necessary healthcare, including prescription drugs. A 2004 attempt at a national strategy for pharmaceutical policy failed because it lacked clear vision, logical planning and commitment from federal and provincial governments. The result of uncoordinated pharmaceutical policies in Canada has been more than a decade of poor system performance. In this essay, we present a framework for a renewed national strategy for pharmaceutical policy. Building on published research and international frameworks, we propose that pharmaceutical policies of federal, provincial and territorial HEALTHCARE POLICY Vol.12 No.1, 2016 [19] governments be coordinated around a core health-focused goal. We strongly suggest policy actions be taken on four core objectives that are necessary to support the overarching health goal. If implemented, the proposed strategy would offer clear benefits to all Canadians who use medicines, federal and provincial governments and to the economy as a whole. We therefore argue that political leadership is now needed to articulate and implement such a plan on behalf of Canadians. RésuméLe Canada doit se doter d' une stratégie nationale afin de respecter son obligation d' assurer un accès universel aux services de santé nécessaires, notamment les médicaments sur ordonnance. La tentative de 2004 en ce sens a connu l'échec en raison d' un manque de vision claire, de planification logique et d' engagement de la part des gouvernements provinciaux et fédéral. Le manque de coordination des politiques relatives aux produits pharmaceutiques au Canada a donné lieu à plus d' une décennie de faible rendement pour le système. Dans cet essai, nous proposons un cadre de travail pour le renouvellement de la stratégie nationale relative aux produits pharmaceutiques. À la lumière de recherches publiées et de cadres de travail internationaux, nous proposons que les politiques des gouvernements provinciaux, territoriaux et fédéral s' articulent autour d' un objectif de santé commun. Nous suggérons fortement que l' action politique porte sur quatre objectifs clés, nécessaires pour appuyer l' objectif de santé commun. Si elle était mise en oeuvre, la stratégie proposée se traduirait par de réels avantages pour les Canadiens qui prennent des médicaments, pour les gouvernements provinciaux et fédéral ainsi que pour l' ensemble de l'économie du pays. Nous affirmons donc, pour le bien-être des Canadiens, qu'il est temps de mettre en place le leadership politique nécessaire pour articuler et mettre en oeuvre un tel plan.

show abstract

Section: Specific Objectives and Strategic Actionsmentioning

confidence: 99%

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada

Morgan

Gagnon

Mintzes

et al. 2016

hcpol

View full text Add to dashboard Cite

show abstract

“…Several studies have demonstrated the association between PIP and adverse drug reactions (ADRs) [3], increase in hospitalizations [4,5], decrease in patients' adherence [6], and excess costs [7,8]. PIP is highly common in older adults [9]; and because of physiological and pathological changes occurring with advancing age, the negative outcomes of PIPs in elderly patients are of great concern [1].…”

Section: Introductionmentioning

confidence: 99%

Influence of hospitalization on potentially inappropriate prescribing among elderly patients in a Malaysian community

Akkawi¹,

Mohamed²

2018

Trop. J. Pharm Res

View full text Add to dashboard Cite

“…Inappropriate prescriptions are a preventable cause of adverse drug reactions which induce patient harm and increase healthcare costs [16]. A Canadian study found that inappropriate medications directed at older patients outside of the hospital setting cost a total of 419 million Canadian dollars in 2013 [17]. Improvements here could prove invaluable.…”

Section: In the Article 'Management Of Older Inpatients Who Refuse Nomentioning

confidence: 99%

Commentary on Management of Older Inpatients who Refuse Non-Psychiatric Medication

Umotong¹

2017

Journal of Neurological Disorders

View full text Add to dashboard Cite

Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study

Cited by 98 publications

References 11 publications

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada

Influence of hospitalization on potentially inappropriate prescribing among elderly patients in a Malaysian community

Commentary on Management of Older Inpatients who Refuse Non-Psychiatric Medication

Contact Info

Product

Resources

About